Tubridge™
The Tubridge™ Flow Diverter is an advanced device designed to provide effective treatment for intracranial aneurysms and other complex cerebrovascular conditions. Leveraging innovative technology and a sophisticated design, Tubridge™ ensures optimal performance, enhanced safety, and improved patient outcomes.
High Flow Diversion Efficacy
Tubridge™ effectively diverts blood flow away from the aneurysm sac, promoting thrombosis within the aneurysm and reducing the risk of rupture.
Flexible and Adaptable Design
Tubridge™ is engineered with a flexible structure that allows for easy conformability in tortuous vascular pathways, ensuring precise placement and stability.
Optimized Porosity
Tubridge™ features optimized porosity, balancing flow diversion and vessel patency to ensure effective treatment without compromising blood supply to the surrounding tissues.
Biocompatible Materials
Made from high-quality biocompatible materials, Tubridge™ minimizes the risk of adverse reactions and promotes endothelialization, enhancing long-term safety and efficacy.
Enhanced Radiopacity
Equipped with radiopaque Wires, Tubridge™ provides excellent visibility under fluoroscopy, facilitating accurate deployment and clearer observation of the expansion process during the procedure.
Product Specifications
IMPACT Clinical Trail
The Tubridge Flow Diverter (TFD) has been evaluated in a clinical trial to assess its safety and effectiveness in treating unruptured intracranial aneurysms located in the internal carotid artery (ICA) and vertebral artery (VA). This prospective, multicenter study involved 200 patients across 14 centers in China, focusing on the ability of the TFD to completely occlude aneurysms over a 12-month period. The results demonstrated a high success rate, with 79% of aneurysms achieving complete occlusion, alongside low rates of disabling stroke and neurological complications.
Download IMPACT Clinical Trial